TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Time to resolution of cardinal DU
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in FMD of the brachial artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Smooth Vergence eye movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rebleeding rate of non-variceal focal UGI lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Composite of cardiac death, nonfatal myocardial infarction, cerebrovascular accident, stent thrombosis, revascularization, and BARC ≥3 bleeding
Endpoint domain: Mortality/survival
Primary endpoint: 25 (OH)D levels in Nmol/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients experiencing any treatment emergent adverse event (TEAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline in pre-bronchodilator percentage (%) predicted FEV1 at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Dyadic Adjustment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Safety of donor lymphocytes labelled with bispecific antibodies
Endpoint domain: Adverse events/effects
Primary endpoint: Comparison of ultrasound elastography to histological examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Comparison of dynamic liver scintigraphy with 99mTc-mebrofenin to histological examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: fœtal vs mother exposure - term
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: fœtal vs mother exposure - length
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: fœtal vs mother exposure - weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Cytomorphometry of the cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Viral Resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Montreal Battery of Evaluation of Amusia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Brain atrophy in MRI scans
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: CERAD (Consortium for Establishing Registry of Alzheimer´s Disease)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Degree of cardiac electrical instability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of patients with early bacteriological failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Percentage of Participants With Adverse Drug Reactions (ADRs): Factor Presence or Absence of History of Therapies for Human Immuno-Deficiency Virus (HIV) Infection
Endpoint domain: Adverse events/effects
Primary endpoint: work time (days)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Postabortal LARC uptake
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Virological Response (Viral Load <50 Copies/mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in functional limitations and symptoms
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Calories Ordered
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Haemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: 6 minute walk test (6MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in brain activity during cognitive tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percent Change in Root Mean Square (RMS) of Electrical Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Correct Targets Identified Minus False Identifications in the n-Back Task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Correctly Recalled Letter Sets in the O-Span Task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in Response Time Between Switch Trials and Non-switch Trials (Switch Cost) in the Task Switching Task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Opioid Consumption Dose 48h After Operation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: PCA Press Frequency 48h After Operation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Body Heat Storage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Muscle Size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Expert Panel Scar Assessment Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Success rate in performing an operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Diagnosis of neuropathy using a ped-mTNS Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Diagnosis of neuropathy using electrochemical skin conductance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Exam grades
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Mixed-meal-stimulated Peak C-peptide Value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: occurrence of atelectasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Handling characteristics of the access needle and needle guide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subjective comfort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: wear time
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of patients in complete or partial remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Displacement of the Endotracheal Tube
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Participants Who Experienced Drug-related AEs and Drug-related SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Grade 3-4 Hematology Abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: maximum FDG uptake (SUVmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in MFI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Morphine consumption 24 hr after surgery
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Acute pain after surgery measured with Numerical Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognition as determined by CDR Continuity of Attention
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Blastocyst utilisation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Patients Defined as Success on the IGA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CD34+ stem cell mobilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hyperoxic chemoreflex sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Family member burden
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: 2 years Disease-Free Survival (DFS) rate
Endpoint domain: Mortality/survival
Primary endpoint: Percent Atheroma Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total radioactivity in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Total radioactivity in whole blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Radioactivity excretion in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in left ventricular filling pressures (E/e')
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in internal tracheal stenosis diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: hormone patterns (FSH, LH, inhibin-B, estradiol)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Eating Disorder Examination Questionnaire (EDE-Q)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Volume Ipsilateral Lymphedema in Arm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes
Primary endpoint: Reclassification rate of CCTA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Favipiravir AUC0-tlast
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Favipiravir Cmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of functional rescue of corpus luteum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Percentage change of GLi levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in alcohol consumption
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: relapse free time
Endpoint domain: Mortality/survival
Primary endpoint: Thickness of common extensor tendon
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Biochemically-verified Smoking Abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With a Depression Event
Endpoint domain: Adverse events/effects
Primary endpoint: Mood Scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of Drinking Days Out of the Past 90 Days
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Binge Drinking Days Out of the Past 90 Days
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Beta-hydroxybutyrate Levels in Blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Nausea Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidence of neurological complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean change in plasma levels of Aβ fragment-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mobility of the intimal flap
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to Recovery of T4/T1 Ratio to 0.9
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Regional brain oxygen saturation (rSO2) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart rate (minute)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxygen saturation (%SpO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inspiratory muscle effort
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Quality of Communication
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Normalisation or Increase of hemaglobin (Hb)-level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Detection of urine iron
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Remission Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Periodontal Screening and Recording (PSR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decayed Missing Filled Teeth Index (DMFT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight loss expressed as Body Mass Index and Percentage Excess Weight Loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alteration in brachial artery flow-mediated dilatation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Allergic reaction to gel components
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Achieving IMACS DOI at Week 24 Without Rescue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Milligram Morphine Equivalent (MME) Units
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life (EORTC QLQ-30)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of sexual life (IIEF)
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Daily urinary phosphate excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Average of daily urinary phosphate excretion over 3-day dosing period
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Production Rate of VLDL-1 Triacylglycerol (TAG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Production Rate VLDL-1 Apoprotein B
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percent Day Abstinent from Alcohol
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acquisition of Adequate Specimens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Hemofiltration circuit survival time
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of metabolic alkalosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of hypernatremia and hyponatremia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in insomnia symptoms
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Reduction in Average Pain
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Length of functional rehabilitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Calcineurin Inhibitor-Related Symptoms (CIRS) severity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Deterioration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of the arginine deiminase system (ADS) in oral samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Intracytoplasmic sperm injection outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Occlusion Rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attempted Surgical Resection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Cmax for [14C] umeclidinium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tmax for [14C] umeclidinium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC for [14C] umeclidinium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: t1/2 for [14C] umeclidinium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: T-Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of oxycodone choices
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Average visual analog scale ratings of I like the choice
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ratio of patients maintaining target serum zinc concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Patient breath retraining skill
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Diabetes self-care activities
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Overall subject success
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Interbeat Interval (IBI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Oxidative Stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mechanosensitivity of neural tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean pain score during hysteroscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in the Measurement of EYE-SYNC Data
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reliability of EYE-SYNC Data
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Integrity of EYE-SYNC Data
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Measurement of anti-thyroid peroxidase levels (anti-TPO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Measurement of thyroglobulin levels (TgAb)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in obstructive BPH symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in irritative BPH symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart-rate-variability (HRV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of patients needing blood transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Time to Complete Wound Re-epithelialization on the Head
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Time to Complete Wound Re-epithelialization on the Lower Extremities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: PROMIS Satisfaction With Social Roles
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Evolution in women's mental health
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Woman's physical health during pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: change in S-25OHD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in serum triglycerides from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in blood metabolomics profile of lipid species from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: survival free of an abnormal diet
Endpoint domain: Mortality/survival
Primary endpoint: Total Volume of Drainage on Each Side of the Face
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of AEs Related to the Investigational Product
Endpoint domain: Adverse events/effects
Primary endpoint: Molecular minimal residual disease biomarker
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Normal histopathology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corneal Oxygen Uptake Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in serum 25-OH vitamin D
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Overall survival for ≥ 2 years
Endpoint domain: Mortality/survival
Primary endpoint: Lipoprotein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Financial toxicity
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: Neuropsychological evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Participants' skin condition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Measurement of Quality of life of the participants
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Measurement of Body Image of the participants
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hepatitis B infection prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Hepatitis A immunity prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes